Opportunity PAR-10-271

The summary for the Opportunity PAR-10-271 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Opportunity PAR-10-271: Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites submission of investigator-initiated Program Project (P01) applications.The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Each P01 application submitted in response to this FOA must include at least two related research projects that share a common central theme, focus, and/or overall objective.Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. Funds Available and Anticipated Number of Awards.The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. Budget and Project Period. Applicants may request support for up to 5 years. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Application Research Strategy Length: The Research Strategy sections of the Overall Program and of each individual Research Project may not exceed 12 pages, and the Core Services Strategy sectionfor the individual Cores may not exceed 6 pages, including tables, graphs, figures, diagrams, and charts.SeeTable of Page Limits.
Federal Grant Title: Opportunity PAR-10-271
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-10-271
Type of Funding: Grant
CFDA Numbers: 93.855
CFDA Descriptions: Allergy, Immunology and Transplantation Research
Current Application Deadline: Sep 07, 2013
Original Application Deadline: Sep 07, 2013
Posted Date: Aug 20, 2010
Creation Date: Sep 16, 2010
Archive Date: Oct 08, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible, however foreign collaborations are encouraged.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Cli...
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowe...
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowe...
Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed)
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com